Novo Nordisk is committed to supporting appropriate independent requests for funding from Healthcare Organisations. Healthcare Organisations interested in seeking a grant are required to complete an application form (see below).
Applications are reviewed by the Novo Nordisk Grant Review Panel throughout the year. Each application will be assessed on its merits and those aligning to Novo Nordisk disease areas will be prioritised.
Application deadlines for 2021: 31 January, 16 April, 16 July, 15 October
Healthcare Organisations interested in seeking a grant from Novo Nordisk are required to complete all sections of the attached application form. Supporting documentation may be provided. The application form must be printed, and then signed and dated by a senior representative of the Healthcare Organisation with the requisite authority to sign on behalf of the Healthcare Organisation. Please return the completed application form to the following email address: UKGRANTS@novonordisk.com
Once received, your application will be reviewed by our Grant Review Panel and you will be informed of their decision. Please take care to include all relevant information at the time of the application. Failure to do so will delay consideration of your application and/or result in it being rejected. You should not consider your application approved until you receive an email from the Grant Review Panel formally notifying you that it has been approved. If you have any questions about your application please email: UKGRANTS@novonordisk.com